Journal of Clinical Immunology

, Volume 19, Issue 5, pp 314–316 | Cite as

TNF-α and Chronic Fatigue Syndrome

  • Ronald B. Moss
  • Alexander Mercandetti
  • Aristo Vojdani
Article

Abstract

Based upon the clinical presentation of chronic fatigue syndrome (CFS), we hypothesized that proinflammatory cytokines may play a role in the pathogenesis of the disease. We therefore undertook a retrospective cross-sectional study to examine the role of TNF-α in patients with CFS. Our results suggest a significant increase serum TNF-α in patients with CFS (P < 0.0001) compared to non-CFS controls. This study supports the further examination of the role of proinflammatory mediators in CFS. Furthermore, the clinical testing of TNF-α blockers and other antiinflammatory agents for the treatment of this disease is warranted.

Chronic fatigue syndrome tumor necrosis factor-α inflammation cytokines 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

REFERENCES

  1. 1.
    Visser J, Blauw B, Hinloopen B, Brommer E, de Kloet ER, Kluft C, Nagelkerken L: CD4 T lymphocytes from patients with chronic fatigue syndrome have decreased interferon-gamma production and increased sensitivity to dexamethasone. J Infect Dis 177(2):451–454, 1998Google Scholar
  2. 2.
    Cannon JG, Angel JB, Abad LW, Vannier E, Mileno MD, Fagioli L, Wolff SM, Komaroff AL: Interleukin-1 beta, interleukin-1 receptor antagonist, and soluble interleukin-1 receptor type II secretion in chronic fatigue syndrome. J Clin Immunol 17(3):253–261, 1997Google Scholar
  3. 3.
    Bennett AL, Chao CC, Hu S, Buchwald D, Fagioli LR, Schur PH, Peterson PK, Komaroff AL: Elevation of bioactive transforming growth factor-beta in serum from patients with chronic fatigue syndrome. J Clin Immunol 17(2):160–166, 1997Google Scholar
  4. 4.
    Buchwald D, Wener MH, Pearlman T, Kith P: Markers of inflammation and immune activation in chronic fatigue and chronic fatigue syndrome. J Rheumatol 24(2):372–376, 1997Google Scholar
  5. 5.
    Levy JA: Viral studies of chronic fatigue syndrome. Clin Infect Dis 18(Suppl 1):S117-S120, 1994Google Scholar
  6. 6.
    Krakauer T, Vilcek J, Oppenheim JJ: Proinflammatory cytokines: TNF and IL-1 families, chemokines, TGF-β, and others. In Fundamental Immunology, 4th ed, WE Paul (ed). New York, Lippincott-Raven, 1999, pp 775–811Google Scholar
  7. 7.
    Feldmann M, Brennan FM, Maini R: Cytokines in autoimmune disorders. Int Rev Immunol 17(1–4):217–228, 1998Google Scholar
  8. 8.
    Gupta S, Aggarwal S, See D, Starr A: Cytokine production by adherent and nonadherent mononuclear cells in chronic fatigue syndrome. J Psychiatr Res 31(1):149–156, 1997Google Scholar
  9. 9.
    Suhadolnik RJ, Reichenbach NL, Hitzges P, Sobol RW, Peterson DL, Henry B, Ablashi DV, Muller WE, Schroder HC, Carter WA, et al.: Upregulation of the 2–5A synthetase/RNase L antiviral pathway associated with chronic fatigue syndrome. Clin Infect Dis 18(Suppl 1):S96-S104, 1994Google Scholar
  10. 10.
    Strayer DR, Carter WA, Brodsky I, Cheney P, Peterson D, Salvato P, Thompson C, Loveless M, Shapiro DE, Elsasser W, et al.: A controlled clinical trial with a specifically configured RNA drug, poly(I).poly(C12U), in chronic fatigue syndrome. Clin Infect Dis 18(Suppl 1):S88-S95, 1994Google Scholar
  11. 11.
    Weinblatt ME, Kremer JM, Bankhurst AD, Bulpitt KJ, Fleischmann RM, Fox RI, Jackson CG, Lange M, Burge DJ: A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med 28;304(4):253–259, 1999Google Scholar
  12. 12.
    Bauditz J, Lochs H, Schreiber S: Chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. N Engl J Med 29;338(5):334, 1998Google Scholar

Copyright information

© Plenum Publishing Corporation 1999

Authors and Affiliations

  • Ronald B. Moss
    • 1
  • Alexander Mercandetti
    • 2
  • Aristo Vojdani
    • 3
  1. 1.The Immune Response CorporationCarlsbad
  2. 2.Alexander MercandettiSan Diego
  3. 3.Immunosciences Laboratory, Inc.Beverly Hills

Personalised recommendations